Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
药物开发及商业化阶段的产品和服务578.1M77.61%
药物研究阶段的产品和服务166.38M22.34%
Other business392.66K0.05%
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
药物研发与生产相关业务1.73B100.00%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Abroad536.13M71.98%
Domestic208.35M27.97%
Other business392.66K0.05%